FDA warned Dream Pharmacy 24/7 for selling unapproved, misbranded opioids, benzodiazepines, and hydroxychloroquine online without prescriptions.
What happened
FDA reviewed Dream Pharmacy 24/7's websites www.premier-dream.com and www.eirmed360.com and found that the company offered tramadol, Opana (oxymorphone), Rivotril (clonazepam), and hydroxychloroquine. The letter says there were no FDA-approved applications in effect for these products and that prescription drugs were offered without requiring a prescription. FDA also flagged hydroxychloroquine listed under "COVID-19 Meds" even though it has not been approved for COVID-19.
What FDA found
Sold tramadol, Opana, Rivotril, and hydroxychloroquine as unapproved drugs without FDA-approved applications.
FD&C Act §§ 301(d), 505(a) [21 U.S.C. §§ 331(d), 355(a)]The prescription drugs' labeling lacked adequate directions for safe use by a layperson.
FD&C Act § 502(f)(1) [21 U.S.C. § 352(f)(1)]; 21 CFR 201.5Offered prescription drugs for sale without requiring a prescription.
FD&C Act §§ 503(b)(1), 301(k) [21 U.S.C. §§ 353(b)(1), 331(k)]Marketed hydroxychloroquine under "COVID-19 Meds" even though FDA has not approved it for COVID-19.
FD&C Act §§ 301(d), 505(a) [21 U.S.C. §§ 331(d), 355(a)]
What FDA wants
Cease offering any violative drugs for sale to U.S. consumers, review websites and labeling, and notify FDA in writing within 15 working days of specific corrective steps and preventive actions.
Who should pay attention
- online pharmacies and website operators selling prescription drugs
- U.S. consumers buying medicines online
- companies whose brand-name products were offered on the sites
This is a summary. Read the original letter on fda.gov.